MeSH term
Frequency | Condition_Probility | Amino Acid Sequence | 12 | 0.0 |
Animals | 26 | 0.0 |
COS Cells | 3 | 0.0 |
Humans | 43 | 0.0 |
Melanoma/*immunology | 5 | 5.0 |
Molecular Sequence Data | 13 | 0.0 |
*Muscle Proteins | 2 | 0.0 |
Protein Biosynthesis | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 29 | 0.0 |
T-Lymphocytes, Cytotoxic/*immunology | 2 | 0.0 |
Transfection | 9 | 0.0 |
Tumor Cells, Cultured | 11 | 0.0 |
Amino Acid Substitution | 4 | 0.0 |
Binding Sites/genetics | 3 | 0.0 |
Cells, Cultured | 3 | 0.0 |
Galanin/analogs & derivatives/*metabolism/pharmacology | 2 | 100.0 |
Hamsters | 2 | 0.0 |
Ligands | 3 | 0.0 |
Models, Molecular | 4 | 0.0 |
Mutagenesis, Site-Directed | 6 | 0.0 |
Receptors, Galanin | 5 | 16.0 |
Female | 10 | 0.0 |
Male | 11 | 0.0 |
Pheromones/*physiology | 2 | 50.0 |
Mice | 12 | 0.0 |
Neoplasm Proteins/immunology | 2 | 5.0 |
Antigen Presentation | 2 | 0.0 |
Cell Line | 3 | 0.0 |
Mice, Inbred C57BL | 4 | 0.0 |
Mice, Knockout | 2 | 0.0 |
Time Factors | 3 | 0.0 |
Adult | 6 | 0.0 |
Alleles | 3 | 0.0 |
Collagen/*genetics | 2 | 0.0 |
*Collagen Type IX | 2 | 33.0 |
Comparative Study | 8 | 0.0 |
Cross-Sectional Studies | 2 | 0.0 |
DNA Mutational Analysis | 2 | 0.0 |
Genetic Predisposition to Disease | 3 | 0.0 |
Middle Aged | 6 | 0.0 |
Hybrid Cells | 2 | 0.0 |
Adenoviridae/genetics | 2 | 0.0 |
Melanoma, Experimental/immunology/*therapy | 2 | 10.0 |
Membrane Proteins/*genetics | 2 | 0.0 |
Aged | 5 | 0.0 |
Aged, 80 and over | 3 | 0.0 |
Case-Control Studies | 2 | 0.0 |
Risk Factors | 2 | 0.0 |
Intervertebral Disk Displacement/diagnosis/*genetics | 2 | 100.0 |
Magnetic Resonance Imaging | 2 | 0.0 |
Point Mutation | 2 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 9 | 0.0 |
Tryptophan/*genetics | 3 | 30.0 |
Binding Sites | 3 | 0.0 |
Calcium/metabolism | 3 | 0.0 |
Conserved Sequence | 2 | 0.0 |
Kinetics | 3 | 0.0 |
Recombinant Proteins/chemistry/metabolism | 3 | 0.0 |
Sequence Alignment | 4 | 0.0 |
Sequence Homology, Amino Acid | 4 | 0.0 |
Chromatography, High Pressure Liquid | 2 | 0.0 |
Mutation | 2 | 0.0 |
*Membrane Glycoproteins | 7 | 0.0 |
*Oxidoreductases | 7 | 8.0 |
Antigens, Neoplasm/*immunology | 2 | 1.0 |
Melanocytes/metabolism | 2 | 5.0 |
Monophenol Monooxygenase/metabolism | 3 | 15.0 |
Proteins/metabolism | 2 | 0.0 |
Protein Structure, Secondary | 2 | 0.0 |
Tryptophan/chemistry | 2 | 5.0 |
Magnetic Resonance Spectroscopy | 3 | 0.0 |
Crystallography, X-Ray | 2 | 0.0 |
Protein Conformation | 2 | 0.0 |
Thermodynamics | 3 | 0.0 |
Base Sequence | 3 | 0.0 |
In Vitro | 3 | 0.0 |
Gene Frequency | 2 | 0.0 |
T-Lymphocytes, Cytotoxic/immunology | 2 | 0.0 |
Cattle | 2 | 0.0 |
Phylogeny | 2 | 0.0 |
*Intramolecular Oxidoreductases | 4 | 25.0 |
Isomerases/metabolism | 2 | 25.0 |
Proteins/*metabolism | 2 | 0.0 |
Rats | 2 | 0.0 |
Structure-Activity Relationship | 3 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
*Chromosomes, Human, Pair 14 | 2 | 1.0 |
RNA, Transfer, Pro/genetics | 2 | 100.0 |
